Ratings Medical Properties Trust, Inc.

Equities

MPW

US58463J3041

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
5.36 ^USD	+7.20%		+6.35%	+9.16%

May. 31	Medical Properties Trust Maintains Quarterly Dividend at $0.15 a Share; Payable July 9 to Shareholders as of June 10	MT
May. 30	Medical Properties Trust, Inc. Declares Regular Quarterly Cash Dividend, Payable on July 9, 2024	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The company's share price in relation to its net book value makes it look relatively cheap.
This company will be of major interest to investors in search of a high dividend stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
One of the major weak points of the company is its financial situation.
Based on current prices, the company has particularly high valuation levels.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
MEDICAL PROPERTIES TRUST, INC.	+9.16%	3.22B	C
WELLTOWER INC.	+14.97%	61.99B	A-
VENTAS, INC.	+0.84%	20.31B	A-
HEALTHPEAK PROPERTIES, INC.	+0.51%	14.01B	A
OMEGA HEALTHCARE INVESTORS, INC.	+5.45%	7.99B	B
HEALTHCARE REALTY TRUST INCORPORATED	-5.80%	6.14B	B-
CARETRUST REIT, INC.	+14.32%	3.63B	C-
SABRA HEALTH CARE REIT, INC.	+2.24%	3.38B	C+
AEDIFICA SA	-6.13%	3.08B	B+
NATIONAL HEALTH INVESTORS, INC.	+18.32%	2.87B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes